Transcan T-Scan 2000 Gets Panel Nod As Mammography Adjunct
This article was originally published in The Gray Sheet
Executive Summary
Transcan Research and Development's T-Scan 2000 transpectral impedance scanner achieves higher sensitivity and specificity rates in target populations than mammography alone, according to data in the firm's premarket approval application presented to FDA's Radiological Devices Panel on Aug. 17 in Rockville, Maryland.